Comparing two groups from lowest to highest scan rate6, patients who scanned more frequently using the FreeStyle Libre systems* spent 43% more Time In Range.
Real-World Data
Analysing the impact of the FreeStyle Libre Portfolio on the lives of real users
Outcomes for people with diabetes
The FreeStyle Libre Portfolio is making a real impact on outcomes for people with diabetes.
Increases Time in Range1
Improves quality of life2
Reduces hypoglycaemia1,3
Decreases HbA1c4
Real-World Data
More frequent use of the FreeStyle Libre systems* increases Time in Range5
Frequent use of the FreeStyle Libre system also resulted in patients spending 26% less Time Below Range (<54 mg/dL)5
The FreeStyle Libre system is clinically proven to significantly reduce hypoglycaemia in T1D1 and T2D3 patients
Increased testing frequency is sustained over time with the FreeStyle Libre system.7
Clinical Evidence
Clinical benefits for a broad range of T1D and
T2D patients.
Webinars
We offer various on-demand webinars for
Healthcare Professionals including
Understanding Time in Range.
References & Disclaimers
Images are for illustrative purposes only. Not real patient, data or healthcare professional.
* FreeStyle Libre systems refers to the FreeStyle Libre system
1. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-2263.
2. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care. 2019. https://doi:10.1136/bmjdrc-2019-000809.
3. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1): 55-73.
4. Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019;42(7):1178-1184. 2020;43(2):389-397.
5. Lang J, Jangam S, Dunn T, Hayter G. Expanded real-world use reaffirms strong correlation between scanning frequency of flash glucose monitoring and glucose control [Poster 972]. Diabetes. 2019;68(suppl 1). https://doi.org/10.2337/db19-972-P.
6. Comparing 2 groups from lowest to highest scan rate (3.6 and 39.5 scans/day).
7. Jangam S, Dunn T, Xu Y, Hayter G, Ajjan R. Flash glucose monitoring improves glycemia in higher-risk patients: a longitudinal, observational study under real-life settings. BMJOpen Diab Res Care 2019;7:e000611. DOl:10.1136/bmjdrc-2018-000611.